paho

Sanofi Pasteur to Leverage Its Strong Vaccine Legacy in Hunt for Zika Vaccine

- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
Press Release

LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.

Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness

Historic Milestone Reflects Successful Collaboration Among MECTIZAN® Donation Program and Partners
Press Release

WHITEHOUSE STATION, N.J., July 29, 2013 /3BL Media/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, applauds the government of Colombia whose work with the MECTIZAN® Donation Program and The Carter Center-sponsored Onchocerciasis Elimination Program for the Americas led to today’s Pan American Health Organization, the World Health Organization’s Regional Office for the Americas (PAHO/WHO), verification of Colombia as the first country in the world to eliminate the transmission of river blindness (onchocerciasis), using MECTIZAN (ivermectin).

Subscribe to paho